Original Article
Author Details :
Volume : 7, Issue : 1, Year : 2021
Article Page : 44-51
https://doi.org/10.18231/j.ijn.2021.008
Abstract
Introduction: Diabetes is one of the most common chronic hyperglycemic syndrome. Diabetic Nephropathy is one of the major complications of DM characterized by persistent albuminuria, increased arterial blood pressure, a relentless decline in glomerular filtration rate (GFR) & a high risk of cardiovascular morbidity & mortality. The biological marker of DN is fibrinogen. Fibrinogen, is increased in diabetic patients. An increase in plasma fibrinogen levels is also considered an independent risk factor for diabetic nephropathy. Fibrinogen is the major coagulation protein in blood.
Objectives:To find out whether the levels of Plasma Fibrinogen levels can be used as markers for the early diagnosis of DN.
Materials and Methods: Study design: A case control study. The study includes total of 150 patients, of which 50 were diabetic without any complications, 50 were diabetic nephropathy patients and remaining 50 were age matched healthy controls.
Results: The mean plasma fibrinogen level in control group was 190.34 72.83 mg/dl. The mean plasma fibrinogen levels in DM & DN groups were 522.76 115.79 mg/dl & 657.64 124.61 mg/dl respectively. In our study, fibrinogen levels were increased significantly in DM group compared to controls which was further increased in DN group. Hence above studies interpret that fibrinogen increases in diabetes with complications.
Conclusion: Fibrinogen correlated positively with FBS, HbA1c , TC, triglyceride, LDL, Blood Urea, serum creatinine, TC/HDL, LDL/HDL & urine A/C ratio in both DM & DN group, whereas there was negative correlation of fibrinogen with HDL & eGFR. Thus fibrinogen could be used as early biomarkers for the diagnosis of DN.
Keywords: Conclusion: Fibrinogen correlated positively with FBS, HbA 1c, TC triglyceride, LDL, Blood Urea serum creatinine, Diabetes Miletus, Diabetic Nephropathy.
How to cite : Ambresh A , Shilpa A, Assessment of plasma fibrinogen as a marker of diabetic nephropathy. IP Indian J Neurosci 2021;7(1):44-51
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 14-01-2021
Accepted : 19-02-2021
Viewed: 1180
PDF Downloaded: 644